Kingstone (KINS) chief actuary exercises 3,334 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kingstone Companies, Inc. Chief Actuary and Senior VP Minlei Chen exercised stock options to acquire 3,334 shares of common stock on January 26, 2025 at an exercise price of $2.25 per share. Following the transaction, Chen directly owns 11,739 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,334 shares exercised/converted
Mixed
2 txns
Insider
Chen Minlei
Role
Chief Actuary, Senior VP
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 3,334 | $0.00 | -- |
| Exercise | Common Stock | 3,334 | $2.25 | $8K |
Holdings After Transaction:
Stock Option — 6,666 shares (Direct);
Common Stock — 11,739 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Kingstone (KINS) executive Minlei Chen report?
Minlei Chen reported exercising stock options to acquire 3,334 shares of Kingstone common stock. The options were exercised on January 26, 2025, converting a derivative award into directly held shares as part of Chen’s equity-based compensation.
At what price did Minlei Chen exercise Kingstone (KINS) stock options?
Chen exercised stock options at an exercise price of $2.25 per share for 3,334 shares of Kingstone common stock. This reflects the pre-set strike price of the option grant rather than an open-market purchase price determined on the transaction date.
Was the Kingstone (KINS) transaction an open-market stock purchase?
No. The filing shows a code M transaction, meaning a stock option exercise, not an open-market purchase. Chen converted 3,334 optioned shares at a fixed $2.25 exercise price into common stock under an existing equity award agreement.
What does the vesting footnote in the Kingstone (KINS) Form 4 explain?
The footnote explains the option’s vesting schedule: 3,334 shares vest on January 5, 2025, and 3,333 shares vest on each of January 5, 2026 and January 5, 2027. The reported exercise uses the portion that vested in early 2025.